Biomea Fusion logo

Biomea Fusion

BMEA | NASDAQ
Chart Builder DCF Calculator
$0.52
-$0.06 (-10.68%)
At close: Nov 16, 2026, 4:00 PM ET
$0.55
+$0.03 (+5.77%)
After-hours: Nov 16, 2026, 6:16 PM ET
-10.68%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
37
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #610/1021 (Top 60%)

Key Statistics

Market Data

Market Cap $37.8M
1D Range
0.52 0.58
52W Range
0.52 2.21

Valuation (TTM)

PE -1.62
PB 4.98
EV/EBITDA -0.54

Valuation (NTM)

Forward PE N/A
Forward PEG 0.03
Price Target $19.00
Loading financial charts...

Profile

Biomea Fusion, Inc., a clinical-stage diabetes and obesity medicines company, focuses on the discovery and development of oral drugs to treat patients with diabetes and obesity. It’s lead clinical pro...

Sector Healthcare
Industry Biotechnology
Employees 37
IPO Date Apr 16, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 10, 2026
EPS
-$0.09
Beat +56.57%
REV
$92K
Beat 0.00%
Next Earnings
Mar 23, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
4
Consensus
Buy
Price Target
$19.00
Upside
+3553.85%
Buy (4)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.